# A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury

> **NCT02687841** · PHASE3 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 206 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** AST-120and pentoxyphylline (PTX)
- **DRUG:** pentoxyphylline (PTX)

## Key facts

- **NCT ID:** NCT02687841
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 206 (ESTIMATED)
- **Last updated:** 2016-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687841, "A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT02687841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*